Clovis Oncology - Barchart's Chart of the Day

Clovis Oncology (CLVS) is the Barchart Chart of the Day. The anti-cancer biopharmaceutical stock has a Trend Spotter buy signal, a Weighted Alpha of 104.20+ and gained 278.00% in the last year.


The Barchart Chart of the Day is Clovis Oncology (CLVS).  I found the stock by sorting Barchart's New High List for frequency in the last month, skipped the stocks that did not have positive results for the last week and month and then used the Flipchart feature to review the charts.  The stock hit a recent low of 43.86 on 11/20 and since then is up 60.17%.

Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report. Barchart technical indicators: 88% Barchart technical buy signals Trend Spotter buy signal Above its 20, 50 and 100 day moving averages 18 new highs and up 32.16% in the last month Relative Strength Index 74.82% Barchart computes a technical support level at 60.50 Recently traded at 70.04 with a 50 day moving average of 56.00 Fundamental factors: Market Cap $2.37 billion Revenue and Earnings estimates are all over the board so there is no real consensus Wall Street brokerage firms issued 1 strong buy, 4 buy and 1 hold recommendation Financial Strength is B+ The price momentum seems to have turned around.  Carefully watch the 50 day moving average for a point to take profits.